Vaughnkofod8154

To investigate trends in data errors over the 40 months after the implementation of an electronic medical record (eMR) system in an Australian regional Drug and Alcohol (D&A) Service.

One hundred and twenty three error reports and data on occasions of service were obtained from the D&A Service. Valemetostat manufacturer Statistical analysis was conducted to describe types of errors, to compare distribution of error types among different documentation forms, D&A Service sites and job roles. Error rates were also analysed.

In the 40 months after the implementation, a total of 18,549 errors occurred. These errors were grouped into four types mismatched data fields (54.5 %), duplicate medical record (1.8 %), date/time error (8.2 %) and blank field (35.4 %). The distribution of error types differed in the forms being completed, the sites and the job roles. Quarterly error rate increased from 28.8 errors per 100 occasions of service in Year 1 Quarter 1-40.6 in Quarter 3, then decreased to 18.1 in Quarter 4. It dropped to 6distribution among the documentation forms, sites and job roles. The findings of this study could be used by eMR trainers to tailor training sessions for specific sites and job roles. These findings might also be useful for managers of other D&A Services to plan for the implementation of new electronic documentation systems.

We previously reported improved outcomes after implementing the electronic-AsthmaTracker (e-AT), a self-monitoring tool for children with asthma, at 11 ambulatory pediatric clinics. This study assesses e-AT adherence and impact across race/ethnicity subgroups.

Secondary data analysis of a prospective cohort study of children ages 2-17 years with persistent asthma, enrolled from January 2014 to December 2015 to use the e-AT for 1 year. Survival analysis was used to compare e-AT use adherence and generalized estimating equation models to compare outcomes pre- and post e-AT initiation, between race/ethnicity subgroups.

Data from 318 children with baseline measurements were analyzed 76.4 % white, 11.3 % Hispanic, 7.8 % "other", and 4.4 % unknown race/ethnicity subgroups. Mean e-AT adherence was 82 % (95 %CI 79-84 %, reference) for whites, 73 % (64-81 %, p = 0.025) for Hispanics, and 78 % (69-86 %, p = 0.373) for other minorities. Compared to whites, Cox proportional hazard ratio for study dropout risk was 2d and ED/hospital use disparities.

Our study shows improved asthma control and QOL among minorities and disparity elimination after e-AT implementation. Future adequately powered studies will explore the impact on oral steroid and ED/hospital use disparities.

The associations between cannabis use and anxiety or depression remain unclear. If cannabis affects these conditions, it is of interest to examine possible changes in cannabis use over time, in relation to anxiety and depression, as cannabis potency has increased in recent decades.

Cohorts from the Women and Alcohol in Gothenburg study (n = 1 100), from three time periods were used to examine associations over time between cannabis use and anxiety and depression. Logistic regression analyses were used and relative excess risk due to interaction (RERI) was calculated to examine potential additive interactions between period of cannabis use, cannabis use, and anxiety or depression.

Cannabis use was associated with anxiety in the oldest cohort (examined 1986-1992, born 1955/65), OR = 5.14 (1.67-15.80, 95 % CI), and with both anxiety and depression in the youngest cohort (examined 2000-2015, born 1980/93), OR = 1.66 (1.00-2.74, 95 % CI) and 2.37 (1.45-3.86, 95 % CI), respectively. RERI was significant between cannabis use and depression in the youngest cohort when compared with older cohorts (1.68 (0.45-2.92, 95 % CI)).

Cross-sectional data prevent statements on causality, though between-cohort comparisons are possible.

The association between cannabis use and depression becomes more pronounced when adding the effect of period of use rather than looking at the effect of cannabis use itself. This study provides clinicians and public health workers with scientifically underpinned knowledge regarding the link between cannabis use and depression, of particular importance given increasing cannabis potency.

The association between cannabis use and depression becomes more pronounced when adding the effect of period of use rather than looking at the effect of cannabis use itself. This study provides clinicians and public health workers with scientifically underpinned knowledge regarding the link between cannabis use and depression, of particular importance given increasing cannabis potency.Herein, the ultra-thin layer MoS2 coverd MoO2 nanocrystal arraying on sulfur-doped graphene framework (MoS2-MoO2/3DSG) is obtained via a simple hydrothermal procedure accompanied with high temperature annealing. Sodium thiosulfate and ethanethiol are used as sulfur sources to form three-dimensional sulfur doped graphene (3DSG) in the hydrothermal process. Importantly, MoO2 nano-particles are uniformly loaded on MoS2 nanosheets and 3DSG via in-situ collaborative technology. As a result, the stable conductive network take full use of the characteristics of high specific capacitance of MoO2 nanoparticles, convenient ion transport channel of two-dimensional MoS2 nanoflakes and efficient charge transfer and cross-linked 3DSG to improve the electrochemical activity and enhance the dynamics of electrons / ions, which is up to 1150.37 F g-1 specific capacitance and maintains 94.6% of the original capacitance after 10,000 cycles. Also, FeS2 nanoflowers in situ loading on 3DSG (FeS2/3DSG) with enhanced the overall performance of the device are fabricated. The asymmetric supercapacitor with the positive electrode of MoS2-MoO2/3DSG and the negative electrode of FeS2/3DSG can work efficiently and stably under the voltage of 1.7 V, and provide energy density of 87.38 Wh kg-1 at the power density of 683.94 Wkg-1, displaying an outstanding application prospect for energy storage.

The electrowetting behavior of droplets can be altered by the inclusion of salts, surfactants, or nanoparticles. We propose that varying the properties of cadmium selenide/zinc sulfide quantum dots will affect the electrowetting behavior of fluorescent nanofluids. Information gathered will allow for greater control of fluid properties when designing a colloidal system in an electrowetting environment.

Aqueous-based quantum dots were functionalized with mercaptocarboxylic acid ligands of various chain length and binding motifs by a room temperature phase transfer method. The size and concentration of the quantum dot were varied, and droplets of the resulting nanofluids were exposed to increasing amounts of voltage. The change in contact angle was evaluated and correlated to the surface chemistry, size, and concentration of the quantum dots.

Quantum dot nanofluids with longer alkyl chains have the most pronounced change in contact angle and were the most stable under applied voltage. The size of the nanoparticles does not significantly impact the electrowetting behavior at low concentration (3µM), but nanofluids containing smaller diameter quantum dots show enhanced electrowetting behavior at higher concentration (27µM).